Thomas Vial

Thomas Vial

Auto-generated profile, based on publicly available information

Thomas Vial

Institut Pasteur, Université Paris Cité, CNRS UMR2000, Insect Infection & Immunity Group, Insect-Virus Interactions Unit, 75015 Paris, France

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ACAvisha Chowdhury
Avisha Chowdhury
CMCassandra Modahl
Cassandra Modahl
STSiok Thing Tan
Siok Thing Tan
BXBenjamin Wong Wei Xiang
Benjamin Wong Wei Xiang
Dorothée MisséDorothée Missé
Dorothée Missé
JPJulien Pompon
Julien Pompon
Arbovirus infection of Aedes aegypti salivary glands (SGs) determines transmission. However, there is a dearth of knowledge on SG immunity. Here, we characterized SG immune response to dengue, Zika and chikungunya viruses using high-throughput transcriptomics. We also describe a transcriptomic response associated to apoptosis, blood-feeding and lipid metabolism. The three viruses differentially regulate components of Toll, Immune deficiency (IMD) and c-Jun N- terminal Kinase (JNK) pathways. However, silencing of the Toll and IMD pathway components showed variable effects on SG infection by each virus. In contrast, regulation of the JNK pathway produced consistent responses in both SGs and midgut. Infection by the three viruses increased with depletion of the activator Kayak and decreased with depletion of the negative regulator Puckered. Virus-induced JNK pathway regulates the complement factor, Thioester containing protein-20 (TEP20), and the apoptosis activator, Dronc, in SGs. Individual and co-silencing of these genes demonstrate their antiviral effects and that both may function together. Co-silencing either TEP20 or Dronc with Puckered annihilates JNK pathway antiviral effect. Upon infection in SGs, TEP20 induces antimicrobial peptides (AMPs), while Dronc is required for apoptosis independently of TEP20. In conclusion, we revealed the broad antiviral function of JNK pathway in SGs and showed that it is mediated by a TEP20 complement and Dronc-induced apoptosis response. These results expand our understanding of the immune arsenal that blocks arbovirus transmission. Arboviral diseases caused by dengue (DENV), Zika (ZIKV) and chikungunya (CHIKV) viruses are responsible for large number of death and debilitation around the world. These viruses are transmitted to humans by the mosquito vector, Aedes aegypti. During the bites, infected salivary glands (SGs) release saliva containing viruses, which initiate human infection. As the tissue where transmitted viruses are produced, SG infection is a key determinant of transmission. To bridge the knowledge gap in vector-virus molecular interactions in SGs, we describe the transcriptome after DENV, ZIKV and CHIKV infection using RNA-sequencing and characterized the immune response in this tissue. Our study reveals the broad antiviral function of c-Jun N-terminal kinase (JNK) pathway against DENV, ZIKV and CHIKV in SGs. We further show that it is mediated by the complement system and apoptosis, identifying the mechanism. Our study adds the JNK pathway to the immune arsenal that can be harnessed to engineer refractory vectors.

27 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JPJulien Pompon
Julien Pompon
RMRonald Morales-Vargas
Ronald Morales-Vargas
MMMenchie Manuel
Menchie Manuel
CTCheong Huat Tan
Cheong Huat Tan
TVThomas Vial
Thomas Vial
Dorothée MisséDorothée Missé
Dorothée Missé
Zika is a mosquito-borne disease associated with neurological disorders that causes an on-going pandemic. The first outbreak was recorded in Micronesia in 2007, then in French Polynesia in 2014 from which it spread to South America in 2015 and ignited a widespread epidemic. Interestingly, Zika outbreaks in Asia remained of moderate intensity although the virus is circulating. To understand these epidemiological variations, we investigated the entomological determinants of ZIKV transmission in Asia. We used oral infection of mosquitoes collected in Singapore to identify the vector species, to quantify the blood infection threshold and to compare transmissibility between an Asian ZIKV strain (H/PF13) and an American strain collected in Brazil (BE H 815744). We have confirmed the vector status of Aedes aegypti and determined that 103 pfu/ml of blood is sufficient to infect mosquitoes. We showed that only the American strain was present in the saliva 3 days post-infection, and that this strain had a 30–40% higher rate of saliva infection in Ae. aegypti from 3 to 14 days post-infection than the Asian strain. Our data suggests that American strains are more efficiently transmitted than Asian strains, which raises concerns about the introduction of American strains in Asia.

25 October 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FDFodé Diop
Fodé Diop
TVThomas Vial
Thomas Vial
PFPauline Ferraris
Pauline Ferraris
SWSineewanlaya Wichit
Sineewanlaya Wichit
MBMichèle Bengue
Michèle Bengue
Dorothée MisséDorothée Missé
Dorothée Missé
Zika virus (ZIKV) is an emerging arbovirus of the Flaviviridae family. Although infection with ZIKV generally leads to mild disease, its recent emergence in the Americas has been associated with an increase in the development of the Guillain-Barré syndrome in adults, as well as with neurological complications, in particular congenital microcephaly, in new-borns. To date, little information is available on neuroinflammation induced by ZIKV, notably in microglial cells in the context of their metabolic activity, a series of chemical transformations that are essential for their growth, reproduction, structural maintenance and environmental responses. Therefore, in the present study we investigated the metabolomic profile of ZIKV-infected microglia. Microglial cells were exposed to ZIKV at different time points and were analyzed by a Liquid Chromatography-High Resolution mass spectrometry-based metabolomic approach. The results show that ZIKV infection in microglia leads to modulation of the expression of numerous metabolites, including lysophospholipids, particulary Lysophosphatidylcholine, and phospholipids such as Phosphatidylcholine, Phosphatidylserine, Ceramide and Sphingomyelin, and carboxylicic acids as Undecanedioic and Dodecanedioic acid. Some of these metabolites are involved in neuronal differentiation, regulation of apoptosis, virion architecture and viral replication. ZIKV infection was associated with concomitant secretion of inflammatory mediators linked with central nervous system inflammation such as IL-6, TNF-α, IL-1β, iNOS and NO. It also resulted in the upregulation of the expression of the gene encoding CX3CR1, a chemokine receptor known to regulate functional synapse plasticity and signaling between microglial cells. These findings highlight an important role for microglia and their metabolites in the process of neuroinflammation that occurs during ZIKV pathogenesis.

21 October 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TVThomas Vial
Thomas Vial
WTWei-Lian Tan
Wei-Lian Tan
EDEric Deharo
Eric Deharo
Dorothée MisséDorothée Missé
Dorothée Missé
Marti GuillaumeMarti Guillaume
Marti Guillaume
JPJulien Pompon
Julien Pompon
Dengue virus (DENV) subdues cell membranes for its cellular cycle by reconfiguring phospholipids in humans and mosquitoes. Here, we determined how and why DENV reconfigures phospholipids in the mosquito vector. By inhibiting and activating the de novo phospholipid biosynthesis, we demonstrated the antiviral impact of de novo–produced phospholipids. In line with the virus hijacking lipids for its benefit, metabolomics analyses indicated that DENV actively inhibited the de novo phospholipid pathway and instead triggered phospholipid remodeling. We demonstrated the early induction of remodeling during infection by using isotope tracing in mosquito cells. We then confirmed in mosquitoes the antiviral impact of de novo phospholipids by supplementing infectious blood meals with a de novo phospholipid precursor. Eventually, we determined that phospholipid reconfiguration was required for viral genome replication but not for the other steps of the virus cellular cycle. Overall, we now propose that DENV reconfigures phospholipids through the remodeling cycle to modify the endomembrane and facilitate formation of the replication complex. Furthermore, our study identified de novo phospholipid precursor as a blood determinant of DENV human-to-mosquito transmission.

9 December 2019 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
TVThomas Vial
Thomas Vial
WTWei-Lian Tan
Wei-Lian Tan
BXBenjamin Wong Wei Xiang
Benjamin Wong Wei Xiang
Dorothée MisséDorothée Missé
Dorothée Missé
EDEric Deharo
Eric Deharo
JPJulien Pompon
Julien Pompon
More than half of the world population is at risk of dengue virus (DENV) infection because of the global distribution of its mosquito vectors. DENV is an envelope virus that relies on host lipid membranes for its life-cycle. Here, we characterized how DENV hijacks the mosquito lipidome to identify targets for novel transmission-blocking interventions. To describe metabolic changes throughout the mosquito DENV cycle, we deployed a Liquid chromatography–high resolution mass spectrometry (LC-HRMS) workflow including spectral similarity annotation in cells, midguts and whole mosquitoes at different times post infection. We revealed a major aminophospholipid reconfiguration with an overall early increase, followed by a reduction later in the cycle. We phylogenetically characterized acylglycerolphosphate acyltransferase (AGPAT) enzyme isoforms to identify those that catalyze a rate-limiting step in phospholipid biogenesis, the acylation of lysophosphatidate to phosphatidate. We showed that DENV infection decreased AGPAT1, but did not alter AGPAT2 expression in cells, midguts and mosquitoes. Depletion of either AGPAT1 or AGPAT2 increased aminophospholipids and partially recapitulated DENV-induced reconfiguration before infection in vitro. However, only AGPAT1 depletion promoted infection by maintaining high aminophospholipid concentrations. In mosquitoes, AGPAT1 depletion also partially recapitulated DENV-induced aminophospholipid increase before infection and enhanced infection by maintaining high aminophospholipid concentrations. These results indicate that DENV inhibition of AGPAT1 expression promotes infection by increasing aminophospholipids, as observed in the mosquito’s early DENV cycle. Furthermore, in AGPAT1-depleted mosquitoes, we showed that enhanced infection was associated with increased consumption/redirection of aminophospholipids. Our study suggests that DENV regulates aminophospholipids, especially phosphatidylcholine and phosphatidylethanolamine, by inhibiting AGPAT1 expression to increase aminophospholipid availability for virus multiplication. Dengue is endemic in tropical and subtropical regions, and has now encroached onto temperate regions because of the geographic expansion of its vector, Aedes aegypti. In the absence of effective vaccine and curative drug, the sole intervention relies on containment strategies using insecticide. However, occurrence of insecticide resistance diminishes vector control efficacy. Here, we explore the nascent field of mosquito metabolomics as part of our discovery effort for new transmission-blocking targets. Dengue virus (DENV) relies on host metabolome, specifically the lipid membrane to complete its life-cycle. However, little is known about how DENV subverts the mosquito physiology. Using high-resolution mass spectrometry, we described metabolic changes incurred by DENV throughout the mosquito cycle, from cellular replication onset to systemic infection. Membrane phospholipids were highly reconfigured and were associated with reduced expression of AGPAT1, an enzyme involved in their biogenesis. AGPAT1 depletion partially recapitulated DENV-induced metabolic reconfiguration and enhanced infection by maintaining high phospholipid concentrations. These phospholipids were then consumed/redirected later in the mosquito DENV cycle. Our work comprehensively describes metabolic changes associated with DENV infection. In addition, we reveal how DENV subdues the lipidome for its benefit by demonstrating the role of phospholipids in mosquito infection.

12 August 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
SMSarah H. Merkling
Sarah H. Merkling
ECElodie Couderc
Elodie Couderc
ACAnna B. Crist
Anna B. Crist
SDStéphanie Dabo
Stéphanie Dabo
JDJosquin Daron
Josquin Daron
LLLouis Lambrechts
Louis Lambrechts
The mosquito Aedes aegypti is the primary vector for dengue virus (DENV), which infects millions of people annually. Variability in DENV susceptibility among wild Ae. aegypti populations is governed by genetic factors, but specific causal variants are unknown. Here, we identify a cytochrome P450-encoding gene (CYP4G15) whose genetic variants drive differences in DENV susceptibility in a natural Ae. aegypti population. CYP4G15 is transiently upregulated in DENV-resistant midguts, while knockdown increases susceptibility, and transgenic overexpression enhances resistance. A naturally occurring 18-base-pair promoter deletion reduces CYP4G15 expression and confers higher DENV susceptibility. The unexpected role of a cytochrome P450 in DENV susceptibility challenges the long-standing focus on canonical immune pathways and opens new avenues for understanding antiviral defense and DENV transmission in mosquitoes.